Valuation Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq 21:00:00 09/09/2026 BST			5-day change	1st Jan Change
54.62 ^USD	-4.88%		-2.64%	+24.00%

09-02	Scholar Rock Receives FDA Fast Track Designation For Apitegromab Facioscapulohumeral Muscular Dystrophy Program As Participant Dosing Commences In Phase 2 FORGE Trial	CI
09-02	Scholar Rock Gets FDA Fast Track, Orphan Drug Designations for Muscular Disorder Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	872.1	467.6	1,356	4,046	4,493	6,652	-	-
Change	-	-46.39%	190.08%	198.32%	11.06%	48.04%	-	-
Enterprise Value (EV) ¹	709.3	414	1,304	3,918	4,270	6,335	6,247	6,282
Change	-	-41.63%	215.07%	200.38%	8.97%	48.37%	-1.39%	0.56%
P/E	-6.92x	-4x	-9.45x	-17.5x	-13.4x	-16.8x	-21.2x	-35.4x
PBR	5.3x	2.07x	6.96x	11x	20.6x	25.1x	22.4x	24.8x
PEG	-	0.1x	0.8x	-0.7x	-0.4x	13.15x	1x	0.9x
Capitalization / Revenue	46.3x	14.1x	-	-	-	1,170x	45.5x	19.1x
EV / Revenue	37.7x	12.5x	-	-	-	1,114x	42.7x	18x
EV / EBITDA	-5.57x	-	-	-	-11.1x	-14.8x	-21.2x	-65.1x
EV / EBIT	-5.46x	-3.08x	-7.62x	-15.5x	-11.1x	-14.5x	-17.9x	-32.7x
EV / FCF	-5.37x	-3.1x	-8.98x	-19.5x	-14.2x	-18.9x	-28.7x	-79.5x
FCF Yield	-18.6%	-32.3%	-11.1%	-5.13%	-7.04%	-5.29%	-3.48%	-1.26%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.59	-2.26	-1.99	-2.47	-3.29	-3.248	-2.572	-1.542
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	18.82	33.19	-	-	-	5.684	146.1	348.8
EBITDA ¹	-127.3	-	-	-	-383	-429	-295.2	-96.48
EBIT ¹	-129.9	-134.4	-171.3	-252.1	-384.6	-437.7	-348.9	-192.3
Net income ¹	-131.8	-134.5	-165.8	-246.3	-377.9	-425.3	-363.8	-213.1
Net Debt ¹	-162.8	-53.53	-51.84	-127.7	-223.8	-317.2	-404.9	-369.9
Reference price ²	24.84	9.05	18.80	43.22	44.05	54.62	54.62	54.62
Nbr of stocks (in thousands)	35,108	51,663	72,143	93,615	102,007	121,785	-	-
Announcement Date	07/03/22	07/03/23	19/03/24	27/02/25	03/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCHOLAR ROCK HOLDING CORPORATION	-16.82x	1114.47x	-14.77x	-.--%	6.65B
WUXI APPTEC CO., LTD.	20.12x	7.11x	14.28x	1.48%	68.52B
ARGENX SE	32.41x	9.38x	45.24x	0.04%	62.88B
INSMED INCORPORATED	-78.84x	15.22x	-73.41x	-.--%	28.13B
WUXI BIOLOGICS (CAYMAN) INC.	29.47x	6.3x	16.34x	-.--%	25.56B
BIONTECH SE	-14.82x	5.45x	-6.85x	-.--%	24.65B
GENMAB A/S	26.99x	5.06x	16.84x	-.--%	19.81B
PHARMAESSENTIA CORPORATION	50.73x	18.74x	38.02x	0.3%	17.69B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1267.09x	36.54x	797.35x	-.--%	14.66B
EXELIXIS, INC.	18.02x	5.37x	12.54x	-.--%	14.45B
Average	133.43x	122.36x	84.56x	0.18%	28.3B
Weighted average by Cap.	76.83x	36.25x	52.25x	0.38%